Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Europa uomo

¹Oncology Centre Antwerp, Antwerp, Belgium. louis.denis@skynet.be

BJU International

|April 11, 2007

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study.

Journal of the American Academy of Dermatology·2023

Same author

Single agent VS-6766 or VS-6766 plus defactinib in <i>KRAS</i>-mutant non-small-cell lung cancer: the RAMP-202 phase II trial.

Future oncology (London, England)·2022

Same author

ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors.

Cell reports. Medicine·2021

Same author

Translational Education.

Biomedicine hub·2020

Same author

Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.

The Journal of allergy and clinical immunology·2019

Same author

Cancer survivorship: an integral part of Europe's research agenda.

Molecular oncology·2018